Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,553 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Significance of post-progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.
Yano Y, Yamamoto A, Minami A, Momose K, Mimura T, Kim SK, Hayashi H, Kado T, Hirano H, Hirohata S, Yoon S, Nishi K, Tei H, Tanaka H, Oouchi S, Matsuura T, Yasutomi E, Hatazawa Y, Shiomi Y, Ueda Y, Kodama Y; Kobe Liver Conference (KLC). Yano Y, et al. JGH Open. 2022 May 25;6(6):427-433. doi: 10.1002/jgh3.12772. eCollection 2022 Jun. JGH Open. 2022. PMID: 35774348 Free PMC article.
Association of Cardiovascular Health Metrics with Risk of Transition to Hypertension in Non-Hypertensive Young Adults.
Suzuki Y, Kaneko H, Yano Y, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Matsunaga A, Node K, McEvoy JW, Lam CSP, Oparil S, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: yano y. Am J Hypertens. 2022 May 25:hpac057. doi: 10.1093/ajh/hpac057. Online ahead of print. Am J Hypertens. 2022. PMID: 35639507
Antihypertensive drugs and cancer risk.
Kidoguchi S, Sugano N, Yokoo T, Kaneko H, Akazawa H, Mukai M, Node K, Yano Y, Nishiyama A; Japanese Society of Hypertension (JSH) working group “Onco-Hypertension”. Kidoguchi S, et al. Among authors: yano y. Am J Hypertens. 2022 May 20:hpac066. doi: 10.1093/ajh/hpac066. Online ahead of print. Am J Hypertens. 2022. PMID: 35595533
Medication Naïve Blood Pressure and Incident Cancers: Analysis of Two Nationwide Population-Based Databases.
Kaneko H, Yano Y, Lee HH, Lee H, Okada A, Itoh H, Morita K, Fukui A, Fujiu K, Suzuki Y, Matsuoka S, Nakamura S, Michihata N, Jo T, Takeda N, Morita H, Yokoo T, Nishiyama A, Node K, Viera AJ, Muntner P, Oparil S, Kim HC, Yasunaga H, Komuro I. Kaneko H, et al. Among authors: yano y. Am J Hypertens. 2022 May 4:hpac054. doi: 10.1093/ajh/hpac054. Online ahead of print. Am J Hypertens. 2022. PMID: 35512273
Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L).
Hayashi H, Yonesaka K, Nakamura A, Fujimoto D, Azuma K, Sakata S, Tachihara M, Ikeda S, Yokoyama T, Hataji O, Yano Y, Hirano K, Daga H, Okada H, Chiba Y, Sakai K, Nishio K, Yamamoto N, Nakagawa K. Hayashi H, et al. Among authors: yano y. Lung Cancer. 2022 Jun;168:38-45. doi: 10.1016/j.lungcan.2022.04.004. Epub 2022 Apr 12. Lung Cancer. 2022. PMID: 35477147 Free article. Clinical Trial.
1,553 results